Sai Life Sciences Limited (BOM:544306)

Market Cap	219.60B +55.2%
Revenue (ttm)	21.70B +39.6%
Net Income	3.33B +141.3%
EPS	15.54 +111.9%
Shares Out	n/a
PE Ratio	65.96
Forward PE	54.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,223
Average Volume	54,888
Open	1,064.50
Previous Close	1,069.50
Day's Range	1,030.05 - 1,064.50
52-Week Range	635.30 - 1,082.25
Beta	n/a
RSI	65.36
Earnings Date	May 15, 2026

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

• Industry: Commercial Physical and Biological Research
• Founded: 1999
• Employees: 3,401
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544306

Financial Performance

In fiscal year 2025, Sai Life Sciences's revenue was 16.95 billion, an increase of 15.66% compared to the previous year's 14.65 billion. Earnings were 1.70 billion, an increase of 105.45%.